Terumo Corporation (TYO:4543)
Japan
· Delayed Price · Currency is JPY | Market Cap | 3.11T |
| Revenue (ttm) | 1.10T |
| Net Income (ttm) | 127.90B |
| Shares Out | 1.48B |
| EPS (ttm) | 86.69 |
| PE Ratio | 24.34 |
| Forward PE | 20.31 |
| Dividend | 30.00 (1.42%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 8,096,600 |
| Average Volume | 7,490,510 |
| Open | 2,108.00 |
| Previous Close | 2,047.50 |
| Day's Range | 2,077.50 - 2,110.00 |
| 52-Week Range | 1,900.00 - 2,859.50 |
| Beta | 0.24 |
| RSI | 54.99 |
| Earnings Date | Feb 13, 2026 |
About Terumo
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,... [Read more]
Financial Performance
In fiscal year 2025, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.
Financial StatementsNews
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMY) Q2 2026 Earnings Call November 12, 2025 3:00 AM EST Company Participants Jin Hagimoto - CFO, CIO, GM of Accounting, Corporate Planning, Tax, IT Planning Dept. & GBS Hi...
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
OXFORD, England and MADISON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd.
Terumo Corporation (TRUMF) Q1 2026 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q1 2026 Earnings Conference Call August 7, 2025 4:00 AM ET Company Participants Jin Hagimoto - CFO, CIO, GM of Accounting, Corporate Planning, Tax, IT Planning Dept. &...
Terumo: Consistent Execution Continues To Drive Solid Growth Metrics
Terumo continues to deliver solid financial results, with steady revenue growth and margin improvement, but share price performance has lagged the broader med-tech sector. The company's strengths lie ...
Terumo Corporation (TRUMF) Q4 2025 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q4 2025 Results Conference Call May 14, 2025 4:00 AM ET Company Participants Jin Hagimoto - Chief Financial Officer Hikaru Samejima - President & Chief Executive Offic...
Terumo Corporation (TRUMF) Q3 2025 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ET Company Participants Jin Hagimoto – Chief Financial Officer Conference Call Participants Jin Hagimoto [Ca...
Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q2 2025 Earnings Conference Call November 7, 2024 3:00 AM ET Company Participants Jin Hagimoto – Chief Financial Officer Hikaru Samejima – Chief Executive Officer Conf...
Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMY) Q4 2024 Results Conference Call May 14, 2024 4:30 AM ET Company Participants Jin Hagimoto - CFO Hikaru Samejima - President, CEO & Director Jin Hagimoto I'm Hagimoto, ...
Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript
Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript
Terumo Corporation (TRUMF) Q2 2024 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q2 2024 Earnings Conference Call November 15, 2023 6:00 AM ET Company Participants Naoki Muto - Chief Accounting Officer & Chief Financial Officer Shinjiro Sato - Chie...
IceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast Symposium
Professor Eisuke Fukuma, who has performed over 600 ProSense breast cancer cryoablation procedures, led a cryoablation symposium with ProSense IceCure joined its exclusive regional distributor, Terumo...
Terumo Corporation (TRUMF) Q1 2024 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q1 2024 Earnings Conference Call August 9, 2023 4:15 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer and Group Executive Officer Confere...
Terumo Corporation (TRUMF) Q4 2023 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q4 2023 Results Conference Call May 15, 2023 4:30 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Antoinette Gawin - President & Chief E...
Terumo Corporation (TRUMF) Q3 2023 Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q3 2023 Earnings Conference Call February 9, 2023 3:00 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Conference Call Participants Naok...
Terumo Corporation A. (TRUMF) Q2 2022 Earnings Call Transcript
Terumo Corporation A. (OTCPK:TRUMF) Q2 2022 Earnings Conference Call November 10, 2022 7:00 AM ET Company Participants Shinjiro Sato - President & Chief Executive Officer Naoki Muto - Chief Accounting...
Terumo Corporation's (TRUMF) Q1 2022 Results - Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q1 202 Earnings Conference Call August 9, 2022 4:00 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Conference Call Participants Naoki M...
Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q4 2021 Results - Earnings Call Transcript
Terumo Corporation (OTCPK:TRUMF) Q4 2021 Earnings Conference Call May 13, 2022 7:00 AM ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Shinjiro Sato - President and CEO Con...
Terumo Corporation (TRUMF) Q3 2021 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) Q3 2021 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q2 2022 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q2 2022 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) Q1 2022 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) Q1 2022 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) Management on Q3 2021 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) Management on Q3 2021 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) CEO Naoki Muto on Q1 2021 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) CEO Naoki Muto on Q1 2021 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q4 2020 Results - Earnings Call Transcript
Terumo Corporation (TRUMF) CEO Shinjiro Sato on Q4 2020 Results - Earnings Call Transcript